Retractable Technologies, Inc. (RVP)
0.6632
0.00 (0.00%)
USD |
NYAM |
Oct 09, 16:00
0.663
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies Enterprise Value : -18.96M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | -18.96M |
| October 08, 2026 | -18.99M |
| October 07, 2026 | -18.13M |
| October 06, 2026 | -18.13M |
| October 05, 2026 | -18.00M |
| October 02, 2026 | -17.95M |
| October 01, 2026 | -18.16M |
| September 30, 2026 | -18.13M |
| September 29, 2026 | -17.95M |
| September 28, 2026 | -18.25M |
| September 25, 2026 | -17.86M |
| September 24, 2026 | -18.37M |
| September 23, 2026 | -18.01M |
| September 22, 2026 | -18.01M |
| September 21, 2026 | -17.56M |
| September 18, 2026 | -17.28M |
| September 17, 2026 | -17.72M |
| September 16, 2026 | -18.45M |
| September 15, 2026 | -18.45M |
| September 14, 2026 | -18.40M |
| September 11, 2026 | -18.45M |
| September 10, 2026 | -17.77M |
| September 09, 2026 | -17.50M |
| September 08, 2026 | -17.86M |
| September 04, 2026 | -17.53M |
| Date | Value |
|---|---|
| September 03, 2026 | -17.44M |
| September 02, 2026 | -17.26M |
| September 01, 2026 | -17.26M |
| August 31, 2026 | -16.90M |
| August 28, 2026 | -16.96M |
| August 27, 2026 | -17.20M |
| August 26, 2026 | -16.96M |
| August 25, 2026 | -16.81M |
| August 24, 2026 | -16.96M |
| August 21, 2026 | -16.96M |
| August 20, 2026 | -16.96M |
| August 19, 2026 | -17.26M |
| August 18, 2026 | -17.26M |
| August 17, 2026 | -17.86M |
| August 14, 2026 | -18.08M |
| August 13, 2026 | -18.49M |
| August 12, 2026 | -18.62M |
| August 11, 2026 | -18.54M |
| August 10, 2026 | -18.75M |
| August 07, 2026 | -18.75M |
| August 06, 2026 | -18.54M |
| August 05, 2026 | -18.76M |
| August 04, 2026 | -18.75M |
| August 03, 2026 | -19.05M |
| July 31, 2026 | -19.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 200.00B |
| AngioDynamics, Inc. | 465.50M |
| Alphatec Holdings, Inc. | 2.138B |
| AtriCure, Inc. | 2.745B |
| Baxter International, Inc. | 19.27B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.831M |
| Revenue (Quarterly) | 7.201M |
| Total Expenses (Quarterly) | 4.370M |
| EPS Diluted (Quarterly) | 0.0926 |
| Gross Profit Margin (Quarterly) | 2.95% |
| Profit Margin (Quarterly) | 39.31% |
| Earnings Yield | -18.15% |
| Normalized Earnings Yield | -16.81 |